Role of Retinoid Receptors in the Regulation of Mucin Gene Expression by Retinoic Acid in Human Tracheobronchial Epithelial Cells

Overview

Journal Biochem J

Specialty Biochemistry

Date 1999 Feb 20

PMID 10024510

Citations 21

Authors

J S Koo

A M Jetten

P Belloni

J H Yoon

Y D Kim

P Nettesheim

Affiliations

Soon will be listed here.

Abstract

To investigate which retinoid receptors are critical in the regulation by all-trans-retinoic acid (RA) of the mucin genes MUC2, MUC5AC and MUC5B in cultured normal human tracheobronchial epithelial (NHTBE) cells, we used pan-RAR-, pan-RXR- and RAR- isotype (alpha, beta and gamma)-selective agonists and RARalpha- and RARgamma-selective antagonists (RAR is RA receptor and RXR is retinoid X receptor). RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM). The pan-RXR-selective agonist by itself did not induce mucin gene expression, but acted synergistically with suboptimal concentrations of the pan-RAR agonist. A retinoid with selective anti-activator-protein-1 activity only marginally induced mucin gene expression. The RARalpha antagonist strongly inhibited mucin gene induction and mucous cell differentiation caused by RA and by the RARalpha- and RARgamma-selective retinoids. In contrast, the RARgamma antagonist only weakly inhibited RARalpha-selective-retinoid-induced mucin gene expression, but completely blocked mucin gene expression induced by the RARgamma-selective retinoid. Our studies indicate that RARalpha is the major retinoid receptor subtype mediating RA-dependent mucin gene expression and mucous cell differentiation, but that the RARgamma isotype can also induce mucin genes. Furthermore these studies suggest that RARbeta is probably not (directly) involved in RA-induced mucin gene expression.

Citing Articles

Development of a micronucleus test using the EpiAirway™ organotypic human airway model.

Munakata S, Watanabe T, Takahashi T, Kimuro S, Ishimori K, Hashizume T Genes Environ. 2023; 45(1):14.

PMID: 37046355 PMC: 10099928. DOI: 10.1186/s41021-023-00269-2.

Baseline serum vitamin A and vitamin C levels and their association with disease severity in COVID-19 patients.

Yilmaz G, Bulut H, Ozden Omaygenc D, Akca A, Can E, Tuten N Acta Biomed. 2023; 94(1):e2023007.

PMID: 36786260 PMC: 9987489. DOI: 10.23750/abm.v94i1.13655.

Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2.

Stephensen C, Lietz G Br J Nutr. 2021; 126(11):1663-1672.

PMID: 33468263 PMC: 7884725. DOI: 10.1017/S0007114521000246.

Recent Advances in the Development of Novel Drug Candidates for Regulating the Secretion of Pulmonary Mucus.

Li X, Jin F, Lee H, Lee C Biomol Ther (Seoul). 2020; 28(4):293-301.

PMID: 32133827 PMC: 7327140. DOI: 10.4062/biomolther.2020.002.

Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis.

Klepsch V, Gerner R, Klepsch S, Olson W, Tilg H, Moschen A Gut. 2017; 67(8):1434-1444.

PMID: 28779026 PMC: 6204953. DOI: 10.1136/gutjnl-2016-313466.

References

Siebert P, Larrick J . PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques. 1993; 14(2):244-9. View

Jetten A, Anderson K, Deas M, Kagechika H, Lotan R, Rearick J . New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Cancer Res. 1987; 47(13):3523-7. View

Meezaman D, Charles P, Daskal E, Polymeropoulos M, Martin B, Rose M . Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem. 1994; 269(17):12932-9. View

Fanjul A, Dawson M, Hobbs P, Jong L, Cameron J, Harlev E . A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994; 372(6501):107-11. DOI: 10.1038/372107a0. View

Benbrook D, Lernhardt E, Pfahl M . A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature. 1988; 333(6174):669-72. DOI: 10.1038/333669a0. View

de The H, Marchio A, Tiollais P, Dejean A . Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J. 1989; 8(2):429-33. PMC: 400823. DOI: 10.1002/j.1460-2075.1989.tb03394.x. View

Krust A, Kastner P, Petkovich M, Zelent A, Chambon P . A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci U S A. 1989; 86(14):5310-4. PMC: 297611. DOI: 10.1073/pnas.86.14.5310. View

de The H, Tiollais P, Stunnenberg H, Dejean A . Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 1990; 343(6254):177-80. DOI: 10.1038/343177a0. View

Mangelsdorf D, Ong E, Dyck J, Evans R . Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 1990; 345(6272):224-9. DOI: 10.1038/345224a0. View

10.

Brand N, Petkovich M, Chambon P . Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-alpha). Nucleic Acids Res. 1990; 18(23):6799-806. PMC: 332734. DOI: 10.1093/nar/18.23.6799. View

11.

Nervi C, Vollberg T, George M, Zelent A, Chambon P, Jetten A . Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res. 1991; 195(1):163-70. DOI: 10.1016/0014-4827(91)90512-s. View

12.

Lehmann J, Dawson M, Hobbs P, Husmann M, Pfahl M . Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res. 1991; 51(18):4804-9. View

13.

Mangelsdorf D, Borgmeyer U, HEYMAN R, Zhou J, Ong E, Oro A . Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992; 6(3):329-44. DOI: 10.1101/gad.6.3.329. View

14.

Martin B, Bernardon J, Cavey M, Bernard B, Carlavan I, Charpentier B . Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmacol. 1992; 5(1):57-65. DOI: 10.1159/000211018. View

15.

Fleischhauer K, Park J, DiSanto J, Marks M, Ozato K, Yang S . Isolation of a full-length cDNA clone encoding a N-terminally variant form of the human retinoid X receptor beta. Nucleic Acids Res. 1992; 20(7):1801. PMC: 312273. DOI: 10.1093/nar/20.7.1801. View

16.

Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F . A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A. 1992; 89(15):7129-33. PMC: 49659. DOI: 10.1073/pnas.89.15.7129. View

17.

Lehmann J, Jong L, Fanjul A, Cameron J, Lu X, Haefner P . Retinoids selective for retinoid X receptor response pathways. Science. 1992; 258(5090):1944-6. DOI: 10.1126/science.1335166. View

18.

Lundgren J, Rieves R, Mullol J, Logun C, Shelhamer J . The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures. Respir Med. 1994; 88(7):511-8. DOI: 10.1016/s0954-6111(05)80333-6. View

19.

Levine S, Larivee P, Logun C, Angus C, Ognibene F, Shelhamer J . Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol. 1995; 12(2):196-204. DOI: 10.1165/ajrcmb.12.2.7865217. View

20.

Majewski S, Marczak M, Szmurlo A, Jablonska S, BOLLAG W . Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids. Cancer Lett. 1995; 89(1):117-24. DOI: 10.1016/0304-3835(95)90166-3. View